Elizabeth I. Read, M.D.

Current Positions:

• Director, Cell and Tissue Therapies, BSRI
• Professor (Adjunct), Department of Laboratory Medicine, University of California, San Francisco

Contact Information:
270 Masonic Ave.
San Francisco, CA 94118
Phone: (415) 749-6607
Fax: (415) 567-5899
Email: eread@bloodsystems.org

Download a scientific summary [pdf file]

Download a curriculum vitae [pdf file]

Back to top

Education:

• A.B., Bryn Mawr College, Bryn Mawr, PA
• M.D., State University of New York at Buffalo, Buffalo, NY

Training/Appointments :

• Intern and Resident, Internal Medicine, George Washington University Medical Center, Washington, D.C.
• Fellow, Hematology/Oncology, George Washington University Medical Center, Washington, D.C.
• Fellow, Transfusion Medicine, NIH Clinical Center, Bethesda, MD
• Associate Professor of Pathology and Director, Stem Cell Transplant Laboratory, University of Utah Medical Center, Salt Lake City, UT
• Medical Director, American Red Cross Blood & Tissue Services, Southern California Region, Los Angeles, CA
• Chief, Cell Processing Section, Department of Transfusion Medicine, NIH Clinical Center, Bethesda, MD

Back to top

Research Interests:

• Bench-to-bedside translation of novel cellular therapies

• Cell therapy product and assay development for clinical trials

• Transfusion issues during hematopoietic transplantation

Publications:

Khuu HM, Cowley H, David-Ocampo V, Carter CS, Kasten-Sports C, Wayne AS, Solomon SR, Bishop MR, Childs RM, Read EJ.  Catastrophic failures of freezing bags for cellular therapy products: Description, cause, and consequences.  Cytotherapy 2002;4:539-49.

Read EJ, Sullivan MT.  Cellular therapy services provided by blood centers and hospitals in the United States, 1999:  an analysis from the Nationwide Blood Collection and Utilization Survey.  Transfusion 2004;44:539-46.

Khuu HM, Stock F, McGann M, Carter CS, Atkins JW, Murray PR, Read EJ.  Comparison of automated culture systems with a CFR/USP-compliant method for sterility testing of cell therapy products.  Cytotherapy 2004;6:183-95.

Fowler DH, Odom J, Castro K, Steinberg SM, Chow CK, Foley J, Kogan Y, Hou J, Wayne A, Gea-Banacloche J, Kasten-Sportes C, Dean R, Wilson WH, Pavletic S, Hakim F, Kolstad A, Leitman S, Read EJ, Fellowes V, Carter CS, Mair R, Beatty GL, Vonderheide RH, Vance BA, Levine BL, June CH, Gress RE, Bishop MR.  Pilot clinical trial of co-stimulated donor Th2-like cells after T cell replete allogeneic hematopoietic stem cell transplantation.  Biol Blood Transplant Med 2006;12:1150-60.

Kurlander RJ, Tawab A, Fan Y, Carter CS, Read EJ.  A functional comparison of mature human dendritic cells prepared in fluorinated ethylene-propylene bags or polystyrene flasks.  Transfusion 2006;46:1494-504.

Khuu HM, Patel N, Carter CS, Murray PR, Read EJ.  Sterility testing of cell therapy products:  Parallel comparison of automated methods with a CFR-compliant method.  Transfusion 2006;46:2071-2082.

Mielke S, Nunes R, Rezvani K, Fellowes VS, Venne A. Solomon SR, Fan Y, Gostick E, Proce DA, Scotto C, Read EJ, Barrett AJ.  A  clinical scale selective allodepletion approach for treatment of HLA-mismatched and matched donor-recipient pairs using expanded T lymphocytes as antigen-presenting cells and a TH9402-based photodepletion technique.  Blood 2008;111:4392-402.

de Silva R, Raval AN, Hadi M, Gildea KM, Bonafacino AC, Yu ZX, Yau YY, Leitman SF, Bacharach SL, Donahue RE, Read EJ, Lederman RJ.  Intracoronary infusion of autologous mononuclear cells from bone marrow or granulocyte-colony stimulating factor –mobilized apheresis product may not improve remodeling, contractile function, perfusion, or infarct size in a swine model of large myocardial infarction.  Eur Heart J 2008;48:647-57.

Back to top